Andrea C. Klaver

α-Synuclein and Anti-α-Synuclein Antibodies in Parkinson’s Disease, Atypical Parkinson Syndromes, REM Sleep Behavior Disorder, and Healthy Controls

Lynnae M. Smith, Mya C. Schiess, Mary P. Coffey et al. · PLoS ONE · 2012 · 64 citations · Full text

Antibody concentrations to Aβ1–42 monomer and soluble oligomers in untreated and antibody–antigen-dissociated intravenous immunoglobulin preparations

Andrea C. Klaver, John M. Finke, Jyothi L. Digambaranath et al. · International Immunopharmacology · 2009 · 48 citations

Allergy, Medicine, Soluble Oligomers +10

CSF lamp2 concentrations are decreased in female Parkinson’s disease patients with LRRK2 mutations

Andrea C. Klaver, Mary P. Coffey, Jan Aasly et al. · Brain Research · 2018 · 35 citations

Neurodegenerative Diseases, Parkinson Disease, Lrrk2 Mutations +7

Measurement of anti-Aβ1–42 antibodies in intravenous immunoglobulin with indirect ELISA: The problem of nonspecific binding

Andrea C. Klaver, Lynnae M. Patrias, Mary P. Coffey et al. · Journal of Neuroscience Methods · 2010 · 34 citations

Allergy, Autoimmune Disease, Intravenous Immunoglobulin +13

Increased Oxidative Stress Markers in Cerebrospinal Fluid from Healthy Subjects with Parkinson’s Disease-Associated LRRK2 Gene Mutations

David A. Loeffler, Andrea C. Klaver, Mary P. Coffey et al. · Frontiers in Aging Neuroscience · 2017 · 34 citations · Full text